Prostate Cancer: Double VS triplet therapy in mHSPC

In recent years, different combinations of #systemictherapy for metastatic hormone-sensitive #prostatecancer (mHSPC) with doublet and even triple therapy have been introduced with different results in clinical trials.

Do you want to know more about Doublet or Triplet Therapy? Don’t miss this Urology Cheat Sheet!

Thanks to Janssen España @JanssenESP for making it possible!

Share

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Subscribe to our newsletter